The effects of intensive blood pressure lowering on markers of mineral metabolism in persons With ckd in sprint

Charles Ginsberg; Ronit Katz; Michel B. Chonchol; Alexander L. Bullen; Kalani L. Raphael; william R. Zhang; walter T. Ambrosius; Jeffrey T. Bates; Javier A. Neyra; Anthony A. Killeen; Henry Punzi; Michael G. Shlipak; Joachim H. Ix

doi:10.2215/CJN.01400220

The effects of intensive blood pressure lowering on markers of mineral metabolism in persons With ckd in sprint

Charles Ginsberg, Ronit Katz, Michel B. Chonchol, Alexander L. Bullen, Kalani L. Raphael, william R. Zhang, walter T. Ambrosius, Jeffrey T. Bates, Javier A. Neyra, Anthony A. Killeen, Henry Punzi, Michael G. Shlipak, Joachim H. Ix

Department of Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	852-854
Number of pages	3
Journal	Clinical Journal of the American Society of Nephrology
Volume	15
Issue number	6
DOIs	https://doi.org/10.2215/CJN.01400220
State	Published - Jun 8 2020

ASJC Scopus subject areas

Epidemiology
Critical Care and Intensive Care Medicine
Nephrology
Transplantation

Access to Document

10.2215/CJN.01400220

Cite this

Ginsberg, C., Katz, R., Chonchol, M. B., Bullen, A. L., Raphael, K. L., Zhang, W. R., Ambrosius, W. T., Bates, J. T., Neyra, J. A., Killeen, A. A., Punzi, H., Shlipak, M. G., & Ix, J. H. (2020). The effects of intensive blood pressure lowering on markers of mineral metabolism in persons With ckd in sprint. Clinical Journal of the American Society of Nephrology, 15(6), 852-854. https://doi.org/10.2215/CJN.01400220

Ginsberg, C, Katz, R, Chonchol, MB, Bullen, AL, Raphael, KL, Zhang, WR, Ambrosius, WT, Bates, JT, Neyra, JA, Killeen, AA, Punzi, H, Shlipak, MG & Ix, JH 2020, 'The effects of intensive blood pressure lowering on markers of mineral metabolism in persons With ckd in sprint', Clinical Journal of the American Society of Nephrology, vol. 15, no. 6, pp. 852-854. https://doi.org/10.2215/CJN.01400220

@article{99fa540f10b44970b0cf230946154897,

title = "The effects of intensive blood pressure lowering on markers of mineral metabolism in persons With ckd in sprint",

author = "Charles Ginsberg and Ronit Katz and Chonchol, {Michel B.} and Bullen, {Alexander L.} and Raphael, {Kalani L.} and Zhang, {william R.} and Ambrosius, {walter T.} and Bates, {Jeffrey T.} and Neyra, {Javier A.} and Killeen, {Anthony A.} and Henry Punzi and Shlipak, {Michael G.} and Ix, {Joachim H.}",

note = "Funding Information: This Work Was supported by the National Institutes of Health (NIH) and the National Research Service Award through the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) grants RO1DK098234 and K24DK110427 to J.H.I. and T32DK104717, F32DK116476, and K23DK118197 to C.G., the NIH Loan Repayment Program to C.G., and the American Heart Association grant 14EIA18560026 to J.H.I. SPRINT is funded With federal funds from the NIH, including the National Heart, Lung, and Blood Institute, the NIDDK, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C, and interagency agreement A-HL-13-002-001. It Was also supported in part With resources and use of facilities through the Department of Veterans Affairs. We also acknowledge the support fromthe following Clinical and Translation Science Awards funded by National Center for Advancing Translational Sciences, Case Western Reserve University, UL1TR000439; Ohio State University, UL1RR025755; University of Pennsylvania, UL1RR024134 and UL1TR000003; Boston University, UL1RR025771; Stanford University, UL1TR000093; Tufts University, UL1RR025752, UL1TR000073, and UL1TR001064; University of Illinois, UL1TR000050; University of Pittsburgh, UL1TR000005; University of Texas, Southwestern, 9U54TR000017-06; University of Utah, UL1TR000105-05; Vanderbilt University, UL1 TR000445; George Washington University, UL1TR000075; University of CA, Davis, UL1 TR000002; University of Florida, UL1 TR000064; University of Michigan, UL1TR000433; Tulane University, P30GM103337 Centers of Biomedical Research Excellence Award National Institute of General Medical Sciences; and Wake Forest University, UL1TR001420. Funding Information: Dr. Chonchol reports grants from Otsuka, grants from Sanofi, and grants from Kadmon outside the submitted work. Dr. Shlipak is a scientific advisor for TAI Diagnostics. All remaining authors have nothing to disclose. Funding Information: This work was supported by the National Institutes of Health (NIH) and the National Research Service Award through the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) grants RO1DK098234 and K24DK110427 to J.H.I. and T32DK104717, F32DK116476, and K23DK118197 to C.G., the NIH Loan Repayment Program to C.G., and the American Heart Association grant 14EIA18560026 to J.H.I.. SPRINT is funded with federal funds from the NIH, including the National Heart, Lung, and Blood Institute, the NIDDK, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C, and interagency agreement A-HL-13-002-001. It was also supported in part with resources and use of facilities through the Department of Veterans Affairs.WealsoacknowledgethesupportfromthefollowingClinical and Translation Science Awards funded by National Center for Advancing Translational Sciences, Case Western Reserve University, UL1TR000439; Ohio State University, UL1RR025755; University of Pennsylvania, UL1RR024134 and UL1TR000003; Boston University, UL1RR025771; Stanford University, UL1TR000093; Tufts University, UL1RR025752, UL1TR000073, and UL1TR001064; University of Illinois, UL1TR000050; University of Pittsburgh, UL1TR000005; University of Texas, Southwestern, 9U54TR000017-06; University of Utah, UL1TR000105-05; Vanderbilt University, UL1 TR000445; George Washington University, UL1TR000075; University of CA, Davis, UL1 TR000002; University of Florida, UL1 TR000064; University of Michigan, UL1TR000433; Tulane University, P30GM103337 Centers of Biomedical Research Excellence Award National Institute of General Medical Sciences; and Wake Forest University, UL1TR001420.",

year = "2020",

month = jun,

day = "8",

doi = "10.2215/CJN.01400220",

language = "English (US)",

volume = "15",

pages = "852--854",

journal = "Clinical Journal of the American Society of Nephrology",

issn = "1555-9041",

publisher = "American Society of Nephrology",

number = "6",

}

TY - JOUR

T1 - The effects of intensive blood pressure lowering on markers of mineral metabolism in persons With ckd in sprint

AU - Ginsberg, Charles

AU - Katz, Ronit

AU - Chonchol, Michel B.

AU - Bullen, Alexander L.

AU - Raphael, Kalani L.

AU - Zhang, william R.

AU - Ambrosius, walter T.

AU - Bates, Jeffrey T.

AU - Neyra, Javier A.

AU - Killeen, Anthony A.

AU - Punzi, Henry

AU - Shlipak, Michael G.

AU - Ix, Joachim H.

N1 - Funding Information: This Work Was supported by the National Institutes of Health (NIH) and the National Research Service Award through the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) grants RO1DK098234 and K24DK110427 to J.H.I. and T32DK104717, F32DK116476, and K23DK118197 to C.G., the NIH Loan Repayment Program to C.G., and the American Heart Association grant 14EIA18560026 to J.H.I. SPRINT is funded With federal funds from the NIH, including the National Heart, Lung, and Blood Institute, the NIDDK, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C, and interagency agreement A-HL-13-002-001. It Was also supported in part With resources and use of facilities through the Department of Veterans Affairs. We also acknowledge the support fromthe following Clinical and Translation Science Awards funded by National Center for Advancing Translational Sciences, Case Western Reserve University, UL1TR000439; Ohio State University, UL1RR025755; University of Pennsylvania, UL1RR024134 and UL1TR000003; Boston University, UL1RR025771; Stanford University, UL1TR000093; Tufts University, UL1RR025752, UL1TR000073, and UL1TR001064; University of Illinois, UL1TR000050; University of Pittsburgh, UL1TR000005; University of Texas, Southwestern, 9U54TR000017-06; University of Utah, UL1TR000105-05; Vanderbilt University, UL1 TR000445; George Washington University, UL1TR000075; University of CA, Davis, UL1 TR000002; University of Florida, UL1 TR000064; University of Michigan, UL1TR000433; Tulane University, P30GM103337 Centers of Biomedical Research Excellence Award National Institute of General Medical Sciences; and Wake Forest University, UL1TR001420. Funding Information: Dr. Chonchol reports grants from Otsuka, grants from Sanofi, and grants from Kadmon outside the submitted work. Dr. Shlipak is a scientific advisor for TAI Diagnostics. All remaining authors have nothing to disclose. Funding Information: This work was supported by the National Institutes of Health (NIH) and the National Research Service Award through the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) grants RO1DK098234 and K24DK110427 to J.H.I. and T32DK104717, F32DK116476, and K23DK118197 to C.G., the NIH Loan Repayment Program to C.G., and the American Heart Association grant 14EIA18560026 to J.H.I.. SPRINT is funded with federal funds from the NIH, including the National Heart, Lung, and Blood Institute, the NIDDK, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke contracts HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C, and interagency agreement A-HL-13-002-001. It was also supported in part with resources and use of facilities through the Department of Veterans Affairs.WealsoacknowledgethesupportfromthefollowingClinical and Translation Science Awards funded by National Center for Advancing Translational Sciences, Case Western Reserve University, UL1TR000439; Ohio State University, UL1RR025755; University of Pennsylvania, UL1RR024134 and UL1TR000003; Boston University, UL1RR025771; Stanford University, UL1TR000093; Tufts University, UL1RR025752, UL1TR000073, and UL1TR001064; University of Illinois, UL1TR000050; University of Pittsburgh, UL1TR000005; University of Texas, Southwestern, 9U54TR000017-06; University of Utah, UL1TR000105-05; Vanderbilt University, UL1 TR000445; George Washington University, UL1TR000075; University of CA, Davis, UL1 TR000002; University of Florida, UL1 TR000064; University of Michigan, UL1TR000433; Tulane University, P30GM103337 Centers of Biomedical Research Excellence Award National Institute of General Medical Sciences; and Wake Forest University, UL1TR001420.

PY - 2020/6/8

Y1 - 2020/6/8

UR - http://www.scopus.com/inward/record.url?scp=85086928402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086928402&partnerID=8YFLogxK

U2 - 10.2215/CJN.01400220

DO - 10.2215/CJN.01400220

M3 - Article

C2 - 32376678

AN - SCOPUS:85086928402

SN - 1555-9041

VL - 15

SP - 852

EP - 854

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

IS - 6

ER -

The effects of intensive blood pressure lowering on markers of mineral metabolism in persons With ckd in sprint

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this